I

Intensity Therapeutics Inc
NASDAQ:INTS

Watchlist Manager
Intensity Therapeutics Inc
NASDAQ:INTS
Watchlist
Price: 0.418 USD 0.24% Market Closed
Market Cap: 25.1m USD

Relative Value

There is not enough data to reliably calculate the relative value of INTS.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INTS Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.8
vs History
vs Industry
Median 3Y
-14.2
Median 5Y
-14.2
Industry
24.1
Forward
-1.2
vs History
vs Industry
Median 3Y
-17.6
Median 5Y
-17.6
Industry
21.8
vs History
vs Industry
Median 3Y
-17.5
Median 5Y
-17.5
Industry
23.8
vs History
87
vs Industry
8
Median 3Y
23.8
Median 5Y
23.8
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
vs Industry
Median 3Y
-14.1
Median 5Y
-14.1
Industry
6.3
vs History
vs Industry
Median 3Y
-14.1
Median 5Y
-14.1
Industry
6.7
Forward
-1.5
vs History
vs Industry
Median 3Y
-17.2
Median 5Y
-17.2
Industry
7.9
vs History
vs Industry
Median 3Y
-17.2
Median 5Y
-17.2
Industry
6.3
vs History
68
vs Industry
8
Median 3Y
75.4
Median 5Y
75.4
Industry
5.5

Multiples Across Competitors

INTS Competitors Multiples
Intensity Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Intensity Therapeutics Inc
NASDAQ:INTS
25.1m USD 0 -2.1 -1.5 -1.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 623 419.7 -159 807.1 -194 056.8 -191 842.4
US
Abbvie Inc
NYSE:ABBV
404.4B USD 6.8 172.2 16.6 23.6
US
Amgen Inc
NASDAQ:AMGN
178.3B USD 5 25.5 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
155.5B USD 5.3 19.2 12.9 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.6B USD 9.9 31.7 23.3 24.3
US
Epizyme Inc
F:EPE
94.1B EUR 2 095.2 -534.6 -582.2 -566.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 5.8 18.1 17.3 19.6
AU
CSL Ltd
ASX:CSL
83B AUD 3.6 18.5 12.5 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.5B USD 16.4 1 206.1 162.6 197.2
NL
argenx SE
XBRU:ARGX
43.8B EUR 14.4 33.9 58.5 60.1
P/E Multiple
Earnings Growth PEG
US
I
Intensity Therapeutics Inc
NASDAQ:INTS
Average P/E: 190.7
Negative Multiple: -2.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 807.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172.2
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.2
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
9%
2
AU
CSL Ltd
ASX:CSL
18.5
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 206.1
N/A N/A
NL
argenx SE
XBRU:ARGX
33.9
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
I
Intensity Therapeutics Inc
NASDAQ:INTS
Average EV/EBITDA: 40.3
Negative Multiple: -1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 056.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.3
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -582.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
11%
1.6
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.6
N/A N/A
NL
argenx SE
XBRU:ARGX
58.5
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
I
Intensity Therapeutics Inc
NASDAQ:INTS
Average EV/EBIT: 46.5
Negative Multiple: -1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 842.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.6
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.3
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
197.2
N/A N/A
NL
argenx SE
XBRU:ARGX
60.1
N/A N/A